HOUSTON, TX (PRWEB) November 18, 2013
ReliantHeart, Inc., the manufacturer of the HeartAssist5® Ventricular Assist Device (VAD), has appointed John V. Soden of Houlihan Lokey to its Board of Directors.
Soden has nearly two decades of experience in investment banking. He is a Managing Director of the Healthcare Group for investment bank Houlihan Lokey where he oversees the firm's medical technologies, diagnostics, life science, and biopharma coverage efforts. Houlihan Lokey specializes in growth company and middle-market advisory; in 2012 it was ranked #1 in terms of the number of completed Mergers and Acquisitions assignments for transactions under $3 billion.
Prior to joining Houlihan Lokey in 2010, Soden was a Managing Director in Healthcare with Thomas Weisel Partners, LLC. Prior to that, he was a Director in both the Healthcare and Mergers and Acquisitions groups at UBS Investment Bank. Soden began his investment banking career as a Financial Analyst at CS First Boston. Soden received a Bachelor's of Arts degree with honors in Economics from Northwestern University.
Soden will bring seasoned judgment to ReliantHeart in the areas of the Company’s performance necessary to create shareholder value. According to Soden: “I am thrilled to be part of this generational change in LVADs, a unique space in medical devices that has very few participants and has been badly in need of a leap forward in innovation in order to improve patient outcomes. ReliantHeart has the potential to radically improve medicine and broaden the current patient population that is able to benefit from these devices.”
For more information about ReliantHeart and the HeartAssist5 VAD, visit http://www.ReliantHeart.com.